This list is an analysis based on recent market events. It's not an investment recommendation.
Annexin Pharmaceuticals AB (publ), a clinical stage biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein and Annexin A5, natural protein that protects and repairs cells, as well as counteract unwanted inflammatory and immune cell reactions. Annexin Pharmaceuticals AB (publ) was incorporated in 2014 and is based in Stockholm, Sweden.
FAQs
What is Annexin Pharmaceuticals AB stock price today?▼
The current price of ANNX-BTA.ST is SEK12.40 SEK — it has decreased by -2.75% in the past 24 hours. Watch Annexin Pharmaceuticals AB stock price performance more closely on the chart.
What is Annexin Pharmaceuticals AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Annexin Pharmaceuticals AB stocks are traded under the ticker ANNX-BTA.ST.
What is Annexin Pharmaceuticals AB market cap?▼
Today Annexin Pharmaceuticals AB has the market capitalization of 20.57M
What is Annexin Pharmaceuticals AB revenue for the last year?▼
Annexin Pharmaceuticals AB revenue for the last year amounts to 0 SEK.
What is Annexin Pharmaceuticals AB net income for the last year?▼
ANNX-BTA.ST net income for the last year is -36.89M SEK.
How many employees does Annexin Pharmaceuticals AB have?▼
As of November 2, 2026, the company has 4 employees.
In which sector is Annexin Pharmaceuticals AB located?▼
Annexin Pharmaceuticals AB operates in the Health & Wellness sector.
When did Annexin Pharmaceuticals AB complete a stock split?▼
Annexin Pharmaceuticals AB has not had any recent stock splits.
Where is Annexin Pharmaceuticals AB headquartered?▼
Annexin Pharmaceuticals AB is headquartered in Stockholm, Sweden.